SAVA logo Cassava Sciences : SAVA

SAVA

Stock Data

$1.51

Change up

$0.06 (4.14%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Cassava Sciences Inc is a biotech firm focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's. Its flagship product, simufilam, has shown promise in early clinical trials. Additionally, Cassava is working on SavaDx, a diagnostic tool aimed at early detection of Alzheimer's through blood tests. Originally known as Pain Therapeutics, the company rebranded in 2019 to better reflect its focus on neuroscience. Based in Austin, Texas, Cassava Sciences continues to pioneer in the field of neurology since its inception in 1998.

All Cassava Sciences Articles

10 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.